Bio Supplies - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 166,326 | 88,677 | 103,169 | 226,610 | 282,184 | 249,344 | 235,635 | 298,332 |
| Profit before tax | 14,352 | 32,487 | 14,300 | 40,774 | 30,160 | 20,300 | 37,060 | 47,037 |
| Net profit | 13,634 | 30,863 | 13,585 | 38,735 | 28,652 | 19,285 | 35,207 | 44,215 |
| Equity | 61,723 | 92,586 | 106,171 | 144,906 | 173,558 | 192,843 | 228,050 | 272,265 |
| Liabilities | 12,346 | 7,600 | 71,537 | 210,079 | 172,722 | 294,302 | 177,610 | 157,239 |
| Non-current assets | 54,866 | 49,141 | 127,306 | 328,669 | 278,576 | 479,052 | 444,837 | 409,742 |
| Current assets | 19,203 | 51,045 | 50,402 | 26,316 | 67,704 | 8,093 | 37,703 | 77,422 |
| Total assets | 74,069 | 100,186 | 177,708 | 354,985 | 346,280 | 487,145 | 482,540 | 487,164 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 23,641 | 46,270 | 44,983 |
| Social insurance contributions | - | - | - | - | - | 1,512 | 15,300 | 17,000 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.7% | -46.7% | +16.3% | +119.6% | +24.5% | -11.6% | -5.5% | +26.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.4% | 30.8% | 7.6% | 10.9% | 8.3% | 4.0% | 7.3% | 9.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 22.1% | 33.3% | 12.8% | 26.7% | 16.5% | 10.0% | 15.4% | 16.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.2% | 34.8% | 13.2% | 17.1% | 10.2% | 7.7% | 14.9% | 14.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.6% | 36.6% | 13.9% | 18.0% | 10.7% | 8.1% | 15.7% | 15.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.7 | 1.4 | 1.0 | 1.5 | 0.8 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 73,923 | 40,927 | 51,585 | 97,120 | 94,061 | 78,739 | 60,162 | 74,583 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bio Supplies - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-08 | 2025-06-09 | 0.80 |
| 2025-05-16 | 2025-06-04 | 0.80 |
| 2025-05-04 | 2025-05-08 | 0.80 |
| 2025-04-24 | 2025-04-29 | 0.80 |
| 2025-01-22 | 2025-01-26 | 7.43 |
| 2025-01-16 | 2025-01-16 | 1476.11 |
| 2024-11-18 | 2024-12-02 | 1336.08 |
| 2024-10-24 | 2024-11-17 | 5.59 |
| 2024-10-16 | 2024-10-17 | 1100.41 |
| 2024-08-19 | 2024-08-21 | 1216.24 |
| 2024-07-24 | 2024-08-18 | 1.28 |
| 2024-07-16 | 2024-07-21 | 1526.05 |
| 2024-05-17 | 2024-05-27 | 23.02 |
| 2024-05-16 | 2024-05-16 | 880.25 |
| 2024-04-23 | 2024-05-15 | 23.02 |
| 2024-04-16 | 2024-04-16 | 1299.31 |
| 2024-04-12 | 2024-04-14 | 34.52 |
| 2024-03-18 | 2024-04-11 | 1753.23 |
| 2024-02-19 | 2024-03-17 | 0.10 |
| 2024-01-23 | 2024-01-28 | 1512.32 |
| 2024-01-16 | 2024-01-22 | 1512.03 |
| 2023-08-17 | 2023-09-05 | 3.20 |
| 2023-07-18 | 2023-08-09 | 3.20 |
| 2023-06-16 | 2023-07-13 | 3.20 |
| 2023-05-16 | 2023-06-14 | 3.20 |
| 2023-05-02 | 2023-05-14 | 3.20 |
| 2023-04-26 | 2023-04-28 | 3.20 |
| 2023-04-18 | 2023-04-25 | 2.40 |
| 2023-03-16 | 2023-04-13 | 2.40 |
| 2023-02-17 | 2023-03-13 | 2.40 |
| 2023-02-14 | 2023-02-14 | 2.40 |
| 2023-01-17 | 2023-01-18 | 885.99 |
| 2022-12-16 | 2022-12-22 | 885.99 |
Bio Supplies - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-19 | 2026-08-20 | 0.76 |
| 2026-08-18 | 2026-08-18 | 4.77 |
| 2026-08-14 | 2026-08-17 | 706.92 |
| 2026-05-19 | 2026-05-19 | 0.08 |
| 2026-04-19 | 2026-04-20 | 17.92 |
| 2026-04-17 | 2026-04-18 | 8.48 |
| 2026-04-15 | 2026-04-16 | 0.22 |
| 2025-12-20 | 2025-12-29 | 0.6 |
| 2025-12-17 | 2025-12-19 | 2.63 |
| 2025-12-09 | 2025-12-16 | 1113.33 |
| 2025-12-06 | 2025-12-08 | 1107.24 |
| 2025-11-28 | 2025-12-05 | 0.6 |
| 2025-11-18 | 2025-11-27 | 6.91 |
| 2025-09-26 | 2025-09-27 | 1.98 |
| 2025-09-10 | 2025-09-11 | 674.82 |
| 2025-07-25 | 2025-07-25 | 2.78 |
| 2025-04-16 | 2025-04-25 | 0.1 |
| 2025-04-11 | 2025-04-15 | 934.9 |
| 2025-04-09 | 2025-04-10 | 968.38 |
| 2025-04-02 | 2025-04-08 | 4.08 |
| 2025-03-16 | 2025-03-17 | 897.15 |
| 2025-02-13 | 2025-02-13 | 1875.38 |
| 2025-01-20 | 2025-01-27 | 8.25 |
| 2025-01-10 | 2025-01-15 | 2054.67 |
| 2024-12-17 | 2024-12-27 | 2.88 |
| 2024-12-13 | 2024-12-16 | 867.71 |
| 2024-12-11 | 2024-12-12 | 895.91 |
| 2024-11-29 | 2024-12-10 | 1.4 |
| 2024-11-28 | 2024-11-28 | 5436.93 |
| 2024-11-18 | 2024-11-23 | 2.25 |
| 2024-10-21 | 2024-10-22 | 3.24 |
| 2024-10-15 | 2024-10-16 | 626.4 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bio Supplies, UAB (code 302728594) is a Private Limited Liability Company engaged in logging. In 2025, the company generated revenue of €298.3K and net profit of €44.2K, compared with €235.6K of revenue and €35.2K of net profit in 2024. This indicates a solid year-on-year improvement, with revenue up 26.6% and profitability remaining stable at a 14.8% net margin. Over the last three years, revenue moved from €249.3K in 2023 to €235.6K in 2024 and then increased to the current level in 2025, while net profit rose from €19.3K to €35.2K and then to €44.2K. At the end of 2025, total assets stood at €487.2K, equity at €272.3K and liabilities at €157.2K. The equity ratio was 55.9%, debt-to-equity 0.58, ROE 16.2% and ROA 9.1%. Asset turnover was 0.61x. Revenue per employee was €74.6K and profit per employee €11.1K.